DNMT1 and neoplasm: Luo et al. [77] also reported that grifolin can phenocopy the effect of DNMT1 inhibitor 5-AZA-2-deoxycytidine and, unlike this epidrug, grifolin is chemically stable and not accompanied by serious side effects and, thus, can be used as a safe alternative to improve tumour control.